SCHEMBL21088130

SCHEMBL21088130

N#CB1CCC(F)(CN)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20008099 0.76 — —
SCHEMBL20008366 0.74 — —
SCHEMBL1751445 0.69 — —
Hydrochloric Acid SCHEMBL17700384 0.67 — —
SCHEMBL20007956 0.65 ALDH1A1 (0.33) —
SCHEMBL21287129 0.65 MAOA (0.61) —
SCHEMBL31715597 0.65 — —
SCHEMBL22990178 0.65 — —
SCHEMBL21287452 0.64 — —
SCHEMBL24230369 0.63 SLC6A3 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558446-B1 NOVEL COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS AC IMMUNE SA (CH) 2019-06-12 — — EP disclosed
Send feedback